Amatoxin poisoning: case reports and review of current therapies
Jeanine Ward1, Kishan Kapadia, Eric Brush
1University of Massachusetts Medical School, Worcester Massachusetts 01655, USA.
Background:
Diagnosis and management of Amanita mushroom poisoning is a challenging problem for physicians across the United States. With 5902 mushroom exposures and two resultant deaths directly linked to Amanita ingestion in 2009, it is difficult for physicians to determine which patients are at risk for lethal toxicity. Identification of amatoxin poisoning can prove to be difficult due to delay in onset of symptoms and difficulty with identification of mushrooms. Consequently, it is difficult for the Emergency Physician to determine proper disposition. Further, treatment options are controversial.
Objectives:
To review current data to help health care providers effectively identify and treat potentially deadly Amanita mushroom ingestions.
Case Reports:
We present two cases of Amanita mushroom ingestion in the northeastern United States treated with N-acetylcysteine, high-dose penicillin, cimetidine, and silibinin, a semi-purified fraction of milk thistle-derived silymarin, as part of their treatment regimen. The mushroom species was identified by a consultant as Amanita Ocreata.
Conclusions:
We present the successful treatment of 2 patients who ingested what we believe to be an Amanita species never before identified in the northeastern United States.
Insights
This study highlights the challenges in diagnosing and treating Amanita mushroom poisoning. It presents a successful treatment regimen for two patients with suspected novel Amanita species ingestion.
Area of Science:
- Toxicology
- Mycology
- Emergency Medicine
Background:
- Amanita mushroom poisoning poses a significant diagnostic and management challenge for US physicians.
- Delayed symptom onset and mushroom identification difficulties complicate risk assessment for lethal toxicity.
- Treatment options for amatoxin poisoning remain controversial.
Observation:
- Two cases of Amanita mushroom ingestion in the northeastern US were treated.
- The specific Amanita species was identified as Amanita Ocreata.
- Treatment included N-acetylcysteine, high-dose penicillin, cimetidine, and silibinin.
Findings:
- Successful treatment of two patients with suspected novel Amanita species ingestion.
- Demonstrates a potential therapeutic approach for severe mushroom poisoning.
Implications:
- Highlights the need for effective diagnostic and treatment strategies for Amanita poisoning.
- Suggests a multimodal treatment approach may be beneficial in managing severe cases.
- Contributes to understanding the clinical presentation and management of rare Amanita species.
Related Concept Videos
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Pharmaceutical Poisoning: Treatment Strategies
Drug Toxicity: Overview
Toxidromes: Clinical Features
Antidotes
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Prevention of Further Absorption of Poison


